Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 4.39 | -2.01% | -0.09 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | N/A | Down | Down |
| Historical VRPX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
| Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -2.01% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible Inside Day | about 14 hours ago |
| Up 3% | about 16 hours ago |
| 50 DMA Support | about 16 hours ago |
| 60 Minute Opening Range Breakout | about 16 hours ago |
| Rose Above 50 DMA | about 16 hours ago |
Get a Trading Sidekick!
- Earnings date: ???
Virpax Pharmaceuticals, Inc. Description
Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Pain Health Sciences Influenza Drug Delivery Euphoriants Pain Management Dosage Forms Analgesics Morphinans Opioids Drug Delivery Systems Bupivacaine Heroin Post Traumatic Stress Disorder Drug Delivery Technologies Morphine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.49 |
| 52 Week Low | 3.7 |
| Average Volume | 2,667,525 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 4.50 |
| 20-Day Moving Average | 4.87 |
| 10-Day Moving Average | 4.73 |
| Average True Range | 0.97 |
| ADX | 65.08 |
| +DI | 32.58 |
| -DI | 8.17 |
| Chandelier Exit (Long, 3 ATRs) | 5.57 |
| Chandelier Exit (Short, 3 ATRs) | 6.82 |
| Upper Bollinger Bands | 6.28 |
| Lower Bollinger Band | 3.47 |
| Percent B (%b) | 0.33 |
| BandWidth | 57.61 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.12 |
| MACD Histogram | -0.1198 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.01 | ||||
| Resistance 3 (R3) | 5.04 | 4.86 | 4.90 | ||
| Resistance 2 (R2) | 4.86 | 4.71 | 4.85 | 4.87 | |
| Resistance 1 (R1) | 4.63 | 4.61 | 4.54 | 4.60 | 4.83 |
| Pivot Point | 4.45 | 4.45 | 4.41 | 4.44 | 4.45 |
| Support 1 (S1) | 4.22 | 4.30 | 4.13 | 4.19 | 3.95 |
| Support 2 (S2) | 4.04 | 4.20 | 4.03 | 3.91 | |
| Support 3 (S3) | 3.81 | 4.04 | 3.88 | ||
| Support 4 (S4) | 3.78 |
